Lisa Stuart

Lisa Stuart serves as a Senior Research Officer at the UWA Medical School and UWA Centre for Medical Research, which is affiliated with the Harry Perkins Institute of Medical Research at The University of Western Australia. Her research profile shows significant contributions to molecular oncology with an h-index of 11 based on 668 citations.

Dr. Stuart's research focuses on molecular mechanisms in cancer development and treatment resistance, with particular expertise in microRNA biology and its applications in hepatocellular carcinoma and prostate cancer. Her work explores how RNA molecules regulate cancer cell behavior, drug resistance mechanisms, and potential therapeutic targets. The research fingerprint analysis shows her strongest contributions in microRNA (100% in Medicine and Dentistry), Hepatocellular Carcinoma (46%), Prostate Cancer (46%), and RNA-binding proteins (30%).

Her publication record demonstrates consistent contributions to high-impact journals including Cell Death & Disease, International Journal of Molecular Sciences, Oncogenesis, and Hepatology. The research trends show increasing focus on overcoming drug resistance in liver cancer through molecular targeting approaches, with recent work expanding into breast cancer mechanisms.

Lisa Stuart actively collaborates with leading cancer researchers across multiple institutions, as evidenced by her co-authorship on interdisciplinary projects. Her research contributes to UN Sustainable Development Goals related to good health and well-being through advancements in cancer understanding and treatment approaches.